- Published:
Association between Feline Immunodeficiency Virus Antibodies and Host Characteristics in Finnish Cats
Samband melian förekomst av antikroppar mot FIV och värdkarakteristika hos kattor i Finland
Acta Veterinaria Scandinavica volume 33, pages 325–334 (1992)
Abstract
Toward the end of 1989 the largest private veterinary laboratory in Finland (Vet/lab) began using a commercial combined ELISA test for Feline Immunodeficiency Virus (FIV) antibodies and Feline Leukemia Virus (FeLV) antigens (Cite ComboR). The overall proportion of FIV seropositive feline samples was 5% during the 22 month study period. The number of tests performed increased slowly while the positive test results decreased with time (7% in 1990 and 4% in 1991). The decrease in prevalence was assumed to reflect a change in the sample population rather than an actual change in the general cat population. There were more symptomatic and domestic cats tested in 1990 than 1991. The lower-risk groups in the second year of the study may simply be an indication that the cat owners became more aware of FIV and the motivation to send samples switched from the veterinarian’s interest to diagnose the disease in a symptomatic cat to the owner’s interest to survey their cats for possible FIV infection. In a multivariable analysis, breed, symptoms, age and sex were associated with the risk of FIV seropositivity The risk increased faster with age in males than in females (i.e., the age effect was not constant between sexes). The cats with symptoms had a higher risk than those without symptoms and non-purebred cats were at a higher risk than purebred cats. FeLV infection was not associated with FIV.
Sammandrag
Finlands största veterinärkliniska laboratorium (Vetlab) som specialiserat sig på diagnostik av sällskapsdjur, har sedan slutet av år 1989 utför ett serologiskt test med ett kombinerat kommersiellt FIV -antikropps och FeLV antigen ELISA-test (CitecomboR). Vid en retrospektiv flervariabelanalys av dessa data som omfattar 22 månaders material, konstateras att FIV -ELISA test-resultaten är beroende av djurets alder, kön, ras och hälsotillstånd. Dessutom konstaterades att ålder och kön tillsammans påverkar testresultatet. FIV och FeLV resultaten visade sig vara statistiskt uberoende av varann. Materialet visar att tyngdpunkten för intresset för testet haller på att förflytta sig från veterinärens diagnostik till djurägarens intresse för sällskapsdjurets hälsotillstånd. Denna trend har medfört att ett mindre antal FIV_utsatta undergrupper har deltagit testet och detta kommer möjligen i längden att minska prevalensen av sjukdomsförekomsten i kliniskt material.
References
Anonymous: Epidemiologic, Graphics, Estimation and Testing Package (EGRET). Statistics and Epidemiologic Research Corporation, Seattle, Washington, 1986 a.
Anonumous: Statistix. Analytical Software, St. Paul, MN, 1989 b.
Barr MC, Pough MB, Jacobson RH, Scott FW: Comparison and interpretation of diagnostic tests for feline immunodeficiency virus infection. J. Amer. vet. med. Ass. 1991, 199, 1377–1381.
Callanan JJ, Hosie MJ, Jarret O: Transmission of feline immunodeficiency virus from mother to kitten. Vet. Rec. 1991, 128, 332–333.
Connaughton D: What you need to know about the feline immunodeficiency virus. J. Amer. vet. med. Ass. 1989, 194, 169–173. Fleming EJ, McCaw DL, Smith JA, Buening GM, Johnson C: Clinical, hematologic, and survival data from cats infected with feline immunodeficiency virus: 42 cases (1983–1988). J. Amer. vet. med. Ass. 1991, 199, 913–916.
Friend SCE, Birch CJ, Lording PM, Marshall JA, Studdert MJ: Feline immunodeficiency virus: prevalence, disease associations and isolation. Aust. vet. J. 1990, 67, 237–243.
Grindem CB, Corbett WT, Ammerman BE, Tomkins MT: Seroepidemiologic survey of feline immunodeficiency virus infection in cats of Wake North Carolina. J. Amer. vet. med. Ass. 1989, 67, 226–228.
Gruffydd-Jones TJ, Hopper CD, Harbour DA, Lutz H: Serological evidence of feline immunodeficiency virus infection in UK cats from 1975–76. Vet. Rec. 1988, 123, 569–570.
Hardy W: General principles of retrovirus immunodetection tests. J. Amer. vet. med. Ass. 1991, 199, 1282–1286.
Hopper CD, Sparkes AH, Gruffydd-Jones TJ, Crispin SM, Muir P, Harbour DA, Stokes CR: Clinical and laboratory findings in cats infected with feline immunodeficiency virus. Vet. Rec. 1989, 125, 341–346.
Hosie MJ, Robertson C, Jarrett O: Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom. Vet. Rec. 1989, 125, 293–297.
Ishida T, Washizu T, Toriyabe K, Motoyoshi S, Tomoda I, Pedersen NC: Feline immunodeficiency virus infection in cats of Japan. J. Amer, vet. med. Ass. 1989, 194, 221–225.
Kleinbaum D, Kupper L, Morgenstern H: Epidemiologic Research: Principles and quantitative methods. Van Nostrand Reinhold, New York 1982.
Knowles JO, Gaskell RM, Gaskell CJ, Harvey CE, Lutz H: Prevalence of feline calicivirus, feline leukaemia virus and antibodies to FIV in cats with chronic stomatitis. Vet. Rec. 1989, 124, 336–338.
Kristensen ATS, Petersen SF, Hoff-Jorgensen, R: Feline AIDS (FAIDS) og Feline Immunodiciency Virus (FIV). Dansk Vet Tidsskr. 1989, 72, 447–452.
Lutz H, Lehmann R, Winkler G, Kottwitz B, Dittmer A, Wolfensberger C, Arnold P: Das Feline Immunschwchevirus in der Schweiz: Klinik und Epidemiologie im Vergleich mit dem Leukmieund dem Coronavirus. Schweiz. (Feline immunodeficiency virus in Switzerland: clinical and epidemiological aspects in comparision with FeLV- and Coronavirus infections). Arch. Tierheilk. 1990, 132, 217–225.
Neu H, Moennig V, Leidinger K, Bussian E: Erste Ergebnisse uber die Verbreitung FIV - (FTLV-) seropositiver Katzen in Deutschland und Interpretation der Ergebnisse. (First results of the distribution of FIV - (FTLV-) seropositive cats in Germany and interpretation of the results). Der praktische Tierarzt 1989, 3, 38–44.
North TW, North GLT, Pedersen NC: Feline Immunodeficiency Virus, a Model for Reverse Transcriptase-Targeted Chemotherapy for Acquired Immune Deficiency Syndrome. Antimicrob. Agents Chemother. 1989, 33, 915–919.
O’Connor TP, Tonelli QJ, Scarlett JM: Report of the National FeLV/FIV Awareness Project. J. Amer. vet. med. Ass. 1991, 199, 1348–1353.
Pedersen NC, Barlough JE: Clinical overview of feline immunodeficiency virus. J. Amer. vet. med. Ass. 1991, 199, 1298–1305.
Pedersen NC, Ho EW, Brown ML, Yamamoto JK: Isolation of a T-Lymphotropic Virus from Domestic Cats with an Immunodeficiency-Like Syndrome. Science 1987, 235, 790–793.
Povey RC, Hawkins GJ: Feline Immunodeficiency virus: a commentary. Can. vet. J. 1989, 30, 559–562.
Sairanen J: Eläintenruokamarkkinat voimakkaassa kasvussa. (Animal food marketing strongly building up). Elintarvikeuutiset 1991, 13, 9–10.
Shelton GH, Waltier RM, Connor SC, Grant CK: Prevalence of Feline Immunodeficiency Virus and Feline Leukaemia Virus Infection in Pet Cats. J. Amer. Anim. Hosp. Ass. 1989, 25, 7–12.
Sukura A, Salminen T, Lindberg L-A: A Survey of FIV Antibodies and FeLV Antigens in Free-roaming Cats in the Capital Area of Finland. Acta vet. scand. 1992, 33, 9–14.
Yamamoto JK, Hansen H, Ho EW, Morishita TY, Okuda T, Sawa TR, Nakamura RM, Pedersen N: Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J. Amer. vet. med. Ass.. 1989 194, 213–220.
Yamamoto JK, Sparger E, Ho EW, Andersen PR, O’Connor T, Mandell CP, Lowenstine L, Munn R, Pedersen NC: Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Amer. J. vet. Res. 1988, 49, 1246–1258.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sukura, A., Gröhn, Y.T., Junttila, J. et al. Association between Feline Immunodeficiency Virus Antibodies and Host Characteristics in Finnish Cats. Acta Vet Scand 33, 325–334 (1992). https://doi.org/10.1186/BF03547298
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1186/BF03547298